Form 10-K Jaguar Health, Inc. For: Dec 31

Related Keywords

Nigeria ,Brazil ,Kenya ,Jordan ,Russia ,Italy ,State Of Delaware ,Delaware ,United States ,California ,Beijing ,China ,India ,Bangladesh ,San Francisco ,Peru ,Ecuador ,Japan ,Pune ,Maharashtra ,New Zealand ,Athens ,Attikír ,Greece ,Wuhan ,Hubei ,Israel ,Texas ,Bahrain ,Woman ,For Post ,Omskaya Oblast ,Venezuela ,Canada ,United Kingdom ,Taiwan ,Kuwait ,Hong Kong ,Zimbabwe ,Saudi Arabia ,Thailand ,Mumbai ,Singapore ,United Arab Emirates ,Ukraine ,Australia ,Qatar ,State Of California ,Iceland ,Credit On ,Ontario ,New York ,Mexico ,Norway ,Washington ,Liechtenstein ,South Korea ,Botswana ,Milan ,Lombardia ,South Africa ,Boston ,Massachusetts ,Americans ,America ,American ,Gulf States ,Italian ,Pravin Chaturvedi ,Stevenr King ,Anula Jayasuriya ,Las Vegas ,Darlene Horton ,Magdalena Biosciences ,Saglik Urunleri Sanayi ,Karen Brunke ,Michael Tempesta ,Lisaa Conte ,Rodman Renshaw ,Carol Lizak ,Lisa Conte ,Jonathanb Siegel ,Steven King ,Jamesj Bochnowski ,Quadri Pharma ,Allergan ,Human Health ,Compensation Program ,European Union ,Stockholders Of Jaguar Health Inc ,Description Of Properties ,Royalty Interest Exchange ,Cardinal Health ,Drug Administration ,Heron Therapeutics Inc ,Committee For Orphan Medicinal Products ,World Health Organization ,Company Stock Incentive Plan See ,Royalty Interest Partitioned The Exchange Transaction ,Seed Mena Businessmen Services ,Board Of Directors The Company ,Glenmark Life Sciences Limited ,Shaman Pharmaceuticals ,Company Common Stock The Conversion ,Exchange Cap ,Company Net Sales On Included Products ,Plant Health Inspection Service ,Quadri Pharmaceuticals Store ,Exchange Agreement ,Community Register Of Medicinal Products ,Health Information Technology For Economic ,Jaguar Health Inc ,Services Agreement ,National Institute Of Biomedical Innovation ,Magdalena Biosciences Inc ,Risk Management Program ,Public Company Accounting Oversight Board United States ,National Cancer Institute ,Development Expense ,Company Third ,Us Supreme Court ,Us Department Of Health Human Services ,Filament Health Corp ,Information For Health Care Providers ,Medicaid Drug Rebate Program ,Pediatric Research Equity ,National Institute Of Allergy ,European Commission ,California Superior Court ,Glenmark Life Sciences Ltd ,Company To Napo Therapeutics ,Animal Health Business Regulations ,National Institute Of Mental Health Disorders ,Uptown The Exchange Agreement ,National Formulary ,Crohn Colitis Foundation ,Napo Pharmaceuticals ,European Commission Inventory Of Union ,Legal Marketing Status For Animal Health Drugs ,Jaguar Health Logo ,Corporation Law ,Salix Pharmaceuticals ,Salix Pharmaceuticals Inc ,Napo Acquisition Corporation Merger Sub ,Drug Assistance Program ,Service Share Amount ,Supreme Court ,Merrill Lynch ,Company Mytesi ,Software Developed For Internal ,Irving Park Capital ,Shaman Pharmaceuticals Inc ,Drug Enforcement Administration ,Jaguar Animal Health ,United Therapeutics Corp ,Jaguar Health ,Deposit Insurance Corporation ,Royalty Exchange ,Compassionate Use Program ,Market Research ,Public Accounting Firm ,Securities Exchange ,Party Transactions ,Committee On Deficit Reduction ,Master Services Agreement ,Ladenburg Thalmann Co ,Allergan Inc ,Us Department Of Commerce ,Health Care ,Clinical Health Act ,Health Education Act ,Knight Therapeutics Inc ,Animal Health ,Bureau Of Industry ,Committee For Medicinal ,Italian Medicines Agency ,Ironwood Pharmaceuticals Inc ,Environmental Protection Agency ,Harvard Medical School ,Centers For Disease ,Company To Investor ,Protocol Assessment For Human Health Prescription Drugs ,Simplification Initiative ,Us Centers For Disease ,Trademark Office ,Pharmaceuticals Inc ,Jaguar Entheogen Therapeutics Initiative ,Royalty Interest The Exchange Transaction ,Library Of Medicinal Plants ,Eu Framework Programme For Research ,Takeda Pharmaceuticals ,Jaguar Animal Health Logo ,Exchange Commission ,Napo Acquisition Corporation ,Us Congress ,Patient Centered Outcomes Research Institute ,Patient Program ,Patient Reported Outcomes See Jaguar Health ,Pediatric Committee ,European Union Pediatric Plan ,Health Insurance Portability ,Breast Cancer Research ,Synergy Pharmaceuticals Inc ,Company To Napo ,Valeant Pharmaceuticals International ,Animal Health Prescription Drugs ,European Union Community ,Nasdaq ,Exchange Agreements ,Small Plant Capital ,Uptown Capital ,Company Seriesg Preferred Stock ,Iliad Research ,National Drug Codes Ndcs Of Mytesi ,Company Ability To ,International Patent Application Publication ,Napo Pharmaceuticals Inc ,Filament Health ,Exchange Transaction ,Cardinal Health On ,Royal Global Amendment Exchange ,Company The Purchase Price ,National Institutes Of Health ,Company Third Amendment ,Sebela Pharmaceuticals Inc ,European Medicines Agency ,Healthcareanalyst Inc ,Royalty Interest Exchange Agreement ,Scientific Strategy Team ,Beth Israel Deaconess Medical Center ,Royalty Exchange The Partitioned ,Vision Research ,Entheogen Therapeutics Initiative ,Abbvie Inc ,Company Common Stocks To Iliad ,Mark One ,Par Value ,Securities Exchange Act ,Interactive Data File ,Regulations T ,Regulations K ,Sarbanes Oxley Act ,Exchange Act ,Nasdaq Capital Market ,Proxy Statement ,Financial Condition ,Napo Therapeutics ,One Small Plant Capital ,Merger Agreement ,Merger Sub ,Ontarget Phase ,Patient Reported Outcomes ,Orphan Drug Designation ,Investigational New Drug ,Jaguar ,Orphan Drug Act ,Scientific Advice ,Colitis Foundation ,One Small Planet ,Strategy Team ,National Institute ,Mental Health Disorders ,National Institutes ,Minor Use ,Major Species ,Infectious Diseases ,Disease Control ,Human Services ,Scientific Advisory Board ,Chief Scientific Officer ,Endoscopy News ,Key Opinion Leaders ,Cluster Differentiation ,People Living ,Healing Forest Conservancy ,Texas Health Science Center ,Mytesi Target ,Vision Research Reports ,People Aged ,Preventing Infections ,Cancer Patients ,Health Care Providers ,Allied Market Research ,Market Global Opportunity Analysis ,Industry Forecast ,Bowel Syndrome Market ,Global Industry Analysis ,Synergy Pharmaceutical Trulance ,Named Patient ,Knight Therapeutics ,Supply Agreement ,License Agreement ,New Drug Application ,Therapeutics Provides New Opportunities ,Treat Orphan Indications Like ,Takeda Pharmaceutical ,Valeant Pharmaceuticals ,Risk Management ,South American ,India Based Glenmark Life Sciences ,Agenzia Italiana Del Farmaco ,Highly Active Antiretroviral Therapy ,Federal Food ,Cosmetic Act ,New Drug Applications ,Human Prescription ,Protocol Assessment ,Human Health Prescription ,Prescription Drug User Fee Act ,Pediatric Research Equity Act ,Approval Requirements ,Human Use ,Veterinary Use ,European Economic Area ,Community Register ,Medicinal Products ,Biomedical Innovation ,Member State ,Member States ,Named Patient Program ,European Public Assessment Report ,Orphan Regulation ,Orphan Medicinal Products ,Trials Regulation ,Clinical Trials Directive ,Clinical Trials Regulation ,Anti Kickback Statute ,Patient Protection ,Affordable Care Act ,Education Reconciliation Act ,Civil False Claims ,False Claims Act ,Civil False Claims Act ,Attorney General ,Accountability Act ,Physician Payments Sunshine Act ,Health Information Technology ,Homeopathic Pharmacopoeia ,New Animal Drug Application ,Minor Species ,Emergency Use Authorization ,Regulatory Pathways ,Legal Marketing Status ,Legally Marketed Unapproved New Animal Drugs ,Environmental Protection ,Federal Trade Commission ,Independent Payment Advisory Board ,Medicare Innovation ,Budget Control Act ,Joint Select Committee ,Deficit Reduction ,American Taxpayer Relief Act ,Federal Food Drug ,Jaguar Animal ,Ironwood Pharmaceuticals ,Sebela Pharmaceuticals ,Chief Executive ,South America ,Animal Medicinal Drug Use Clarification Act ,Chief Executive Officer ,Foreign Assets Control ,Corrupt Practices Act ,Streeterville Capital ,Security Agreement ,Leahy Smith America Invents Act ,Leahy Smith Act ,United States Patent ,Hatch Waxman Act ,Orange Book ,Napo Logo ,Federal Register ,Dietary Supplement ,Veterinary Medicine ,Generally Recognized ,Additive Petition ,Neonorm Foal ,Neonorm Calf ,Nasdaq Capital ,Ladenburg Thalmann ,Delaware General Corporation ,Under Section ,Delaware General Corporation Law ,Dodd Frank Wall Street Reform ,Consumer Protection Act ,Annual Report ,Chief Compliance Officer ,Chief Financial Officer ,Current Report ,Securities Act ,Napo Therapeutic ,Cleveland Clinic ,Fair Value ,Financial Instruments ,Hybrid Instrument Designated ,Fair Value Option ,Accounting Policies ,Significant Judgments ,Years Ended December ,Assistance Program ,Product Revenue ,Hybrid Financial Instruments Designated ,Year Ended December ,Ended December ,Independent Registered Public Accounting ,Public Company Accounting Oversight Board ,Seriesh Preferred ,Seriesi Preferred ,Seriesg Preferred ,Royal Global Amendment ,Royal Interest Global ,Consolidated Financial ,Nasdaq Listing Rule ,Significant Accounting Policies ,Federal Deposit Insurance Corporation ,Long Lived Assets ,Business Combinations ,Exclusive Distribution Agreement ,Wholesaler Acquisition Cost ,Specialty Product Distribution Agreement ,National Drug Codes ,Specialty Pharmacy Distribution ,Troubled Debt Restructuring ,Stock Incentive Plan ,Common Stock ,Income Taxes Related ,Uncertain Tax ,Currency Remeasurement ,Foreign Currency Matters ,Comprehensive Income ,Diluted Net Loss Per Common ,Codification Amendments ,Regulations X ,Value Measurements ,Fair Value Measurements ,Streeterville Note ,Return Bonus ,Tropical Disease Priority Review Voucher ,Cash Flows ,Value Over ,Director Compensation ,Asset Transfer ,Transition Agreement ,Future Royalty ,Royalty Repayment Amount ,Purchase Price Date ,Royalty Payment ,Royalty Interest ,Interest Global ,Royalty Interests ,Nasdaq Minimum Price ,Royalty Interest Global Amendments ,Standstill Date ,Standstill Agreement ,Seriesh Convertible Preferred Stock ,Standstill Period ,Standstill Investor ,Global Amendment ,Common Stocks ,Net Sales ,Included Products ,Seriesi Convertible Preferred Stock ,Minimum Price ,Nasdaq Listing ,Seriesi Preferred Stock ,Interest Exchange ,Partitioned Royalty ,Royalty Financing ,Trial Failure Effect ,Mandatory Default Amount ,Default Effect ,Salix Waiver ,First Insurance Funding ,First Insurance ,License Termination ,Settlement Agreement ,Securities Purchase Agreement ,Seriesg Convertible Preferred Stock ,Private Placement ,Voting Cap ,Conversion Cap ,Initial Exercise ,Common Stock Equivalents ,First Amendment ,Warrants Initial Exercise ,Standstill Warrants ,Stockholder Approval ,Warrant Initial Exercise ,Standstill Warrant Initial Exercise ,Interest Global Amendment ,Royalty Interest Global Amendment Warrants ,Interest Global Amendment Initial Exercise ,Seriese Preferred Stock ,Seriesg Preferred Stock ,Third Amended ,Restated Certificate ,Authorized Share Increase ,Sixth Amendment ,Authorized Share ,Third Amendment ,Market Offering ,Based Compensation ,Incentive Plan ,Registration Statement ,Employee Inducement Award ,New Employee Inducement Award Plan ,Inducement Award Plan ,Inducement Award ,Award Plan ,Nasdaq Listing Rules ,Restricted Stock Units ,Loss Per Share Attributable ,Common Stockholders ,Internal Revenue Code Section ,Coronavirus Aid ,Economic Security Act ,Consolidated Appropriations Act ,Tax Positions ,Tax Positions Taken During ,Agreement Extinguishment ,Seriesj Preferred Stock ,Streeterville Exchange Agreement ,Streeterville Exchange Transaction ,Seriesj Perpetual Preferred ,Licensing Agreement ,Eastern Europe ,Principal Financial ,Accounting Officer ,Internal Control Integrated Framework ,Sponsoring Organization ,Treadway Commission ,Internal Control ,Certain Beneficial Owners ,Executive Officers ,Equity Compensation ,Independent Registered Public Accounting Firm ,Principal Accountant Fees ,Executive Officer ,Principal Executive Officer ,Financial Officer ,